Who owns Cue Biopharma Inc?
- Ticker: CUE
- CUSIP Number: 22978p106
Tip: Access positions for across all investors
Analyze quarterly positions in Cue Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cue Biopharma stock
Who bought or sold Cue Biopharma Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 2.1M | $5.6M | 0% | Dec 2023 |
|
| Bleichroeder | 1.8M | $4.6M | 132% | Dec 2023 |
|
| Robertson Stephens Wealth Management | 479k | $1.3M | 0% | Dec 2023 |
|
| Dimensional Fund Advisors | 458k | $1.2M | -19% | Dec 2023 |
|
| Monaco Asset Management SAM | 342k | $904k | -5% | Dec 2023 |
|
| Millennium Management | 276k | $728k | -12% | Dec 2023 |
|
| Bank of America Corporation | 266k | $703k | 41% | Dec 2023 |
|
| Stifel Financial | 194k | $512k | 32% | Dec 2023 |
|
| Bank of New York Mellon | 109k | $289k | 6% | Dec 2023 |
|
| Sigma Planning | 109k | $287k | -56% | Dec 2023 |
|
| Charles Schwab Investment Management | 106k | $279k | 10% | Dec 2023 |
|
| Good Life Advisors | 100k | $264k | -11% | Dec 2023 |
|
| UBS Group | 99k | $262k | 25% | Dec 2023 |
|
| HighTower Advisors | 78k | $206k | 0% | Dec 2023 |
|
| Citadel Advisors | 75k | $197k | -39% | Dec 2023 |
|
| Annandale Capital | 65k | $172k | 0% | Dec 2023 |
|
| Goldman Sachs Group | 58k | $154k | 205% | Dec 2023 |
|
| CornerCap Investment Counsel | 58k | $153k | 0% | Dec 2023 |
|
| Barclays | 56k | $146k | 362% | Dec 2023 |
|
| Jane Street | 55k | $144k | 100% | Dec 2023 |
|
| Squarepoint Ops | 44k | $115k | 131% | Dec 2023 |
|
| Wedmont Private Capital | 40k | $76k | 100% | Mar 2024 |
|
| Occudo Quantitative Strategies | 33k | $88k | 100% | Dec 2023 |
|
| Baker Avenue Asset Management | 32k | $86k | 0% | Dec 2023 |
|
| Rhumbline Advisers | 32k | $84k | 1% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 30k | $79k | 1169% | Dec 2023 |
|
| Wells Fargo & Company | 29k | $78k | -62% | Dec 2023 |
|
| Nantahala Capital Management | 27k | $71k | 0% | Dec 2023 |
|
| Navalign | 25k | $47k | 0% | Mar 2024 |
|
| Caption Management | 25k | $65k | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 22k | $59k | 0% | Dec 2023 |
|
| AQR Capital Management | 22k | $59k | -6% | Dec 2023 |
|
| Cambridge Investment Research Advisors | 22k | $42k | 0% | Mar 2024 |
|
| T. Rowe Price Associates | 18k | $49k | 10% | Dec 2023 |
|
| American International | 18k | $47k | 4% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 17k | $44k | -23% | Dec 2023 |
|
| GSA Capital Partners | 14k | $37k | 100% | Dec 2023 |
|
| SeaCrest Wealth Management | 13k | $25k | -7% | Mar 2024 |
|
| Royal Bank of Canada | 13k | $32k | 21% | Dec 2023 |
|
| New York State Common Retirement Fund | 12k | $31k | -1% | Dec 2023 |
|
| Beacon Pointe Advisors | 10k | $26k | 0% | Dec 2023 |
|
| Legacy Capital Group California | 10k | $26k | 100% | Dec 2023 |
|
| Gleason Group | 6.0k | $11k | 0% | Mar 2024 |
|
| Citigroup | 5.6k | $15k | 15860% | Dec 2023 |
|
| Legal & General Group | 4.2k | $11k | 0% | Dec 2023 |
|
| Newbridge Financial Services Group | 3.0k | $7.9k | -25% | Dec 2023 |
|
| Summit Investment Advisors | 2.9k | $7.5k | 0% | Dec 2023 |
|
| Amalgamated Bank | 1.2k | $2.0k | -76% | Mar 2024 |
|
| American Capital Advisory | 1.0k | $2.6k | 100% | Dec 2023 |
|
| Beaird Harris Wealth Management | 797.00 | $2.1k | 0% | Dec 2023 |
|
| Harbour Investments | 439.00 | $1.2k | 0% | Dec 2023 |
|
| Sunbelt Securities | 237.00 | $448.001100 | 0% | Mar 2024 |
|
| Advisory Services Network | 200.00 | $528.000000 | 100% | Dec 2023 |
|
| Russell Investments | 172.00 | $453.994000 | 42% | Dec 2023 |
|
| Armstrong Advisory Group | 120.00 | $317.004000 | 0% | Mar 2024 |
|
| IFP Advisors | 100.00 | $264.000000 | 100% | Dec 2023 |
|
| Advisor Group Holdings | 62.00 | $164.002400 | 0% | Dec 2023 |
|
| Farther Finance Advisors | 22.00 | $58.000800 | 100% | Dec 2023 |
|
| NISA Investment Advisors | 20.00 | $53.000000 | 100% | Dec 2023 |
|
| CWM | 2.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Cue Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Simplex Trading | Sep 2023 | 22k | $51k |
| Wolverine Trading | Sep 2023 | 11k | $26k |